Nuzenio

Bcyc

Bcyc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Rating of "Hold" by Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:39:16 GMTBicycle Therapeutics (BCYC) Holds Above $3.77 Support, Climbs 0.76% to $3.97 - Elliott Wave Entry - dars.gov.etdars.gov.et · Wed, 05 Aug 2026 21:44:04 GMTBicycle: 'Hold' On Zelenectide Deprioritization And Shift To EphA2+ Tumor Targeting - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 14:40:25 GMTBicycle Therapeutics Stock Price Forecast. Should You Buy BCYC? - StockInvest.usStockInvest.us · Fri, 31 Jul 2026 22:25:45 GMTBCYC Looks 71.1% Undervalued on GF Value™ - GuruFocusGuruFocus · Fri, 31 Jul 2026 17:16:17 GMTAnalysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 16:50:00 GMTOppenheimer Adjusts Price Target on Bicycle Therapeutics to $11 From $36, Maintains Outperform Rating - MoomooMoomoo · Fri, 31 Jul 2026 13:31:03 GMTOppenheimer Initiates Bicycle Therapeutics(BCYC.US) With Buy Rating, Announces Target Price $11 - MoomooMoomoo · Fri, 31 Jul 2026 13:31:00 GMT

Timeline

Sat, 08 Aug 2026 06:39:16 GMTBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Wed, 05 Aug 2026 21:44:04 GMTBicycle Therapeutics (BCYC) Holds Above $3.77 Support, Climbs 0.76% to $3.97 - Elliott Wave Entry - dars.gov.et
Tue, 04 Aug 2026 14:40:25 GMTBicycle: 'Hold' On Zelenectide Deprioritization And Shift To EphA2+ Tumor Targeting - Seeking Alpha
Fri, 31 Jul 2026 22:25:45 GMTBicycle Therapeutics Stock Price Forecast. Should You Buy BCYC? - StockInvest.us
Fri, 31 Jul 2026 17:16:17 GMTBCYC Looks 71.1% Undervalued on GF Value™ - GuruFocus
Fri, 31 Jul 2026 16:50:00 GMTAnalysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE) - The Globe and Mail

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Bcyc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.